288 related articles for article (PubMed ID: 23213058)
1. Tumoral lymphocytic infiltration and expression of the chemokine CXCL10 in breast cancers from the Ontario Familial Breast Cancer Registry.
Mulligan AM; Raitman I; Feeley L; Pinnaduwage D; Nguyen LT; O'Malley FP; Ohashi PS; Andrulis IL
Clin Cancer Res; 2013 Jan; 19(2):336-46. PubMed ID: 23213058
[TBL] [Abstract][Full Text] [Related]
2. Role of CXCL10 in the progression of in situ to invasive carcinoma of the breast.
Kim M; Choi HY; Woo JW; Chung YR; Park SY
Sci Rep; 2021 Sep; 11(1):18007. PubMed ID: 34504204
[TBL] [Abstract][Full Text] [Related]
3. CXCR3 Ligands in Cancer and Autoimmunity, Chemoattraction of Effector T Cells, and Beyond.
Karin N
Front Immunol; 2020; 11():976. PubMed ID: 32547545
[TBL] [Abstract][Full Text] [Related]
4. Wrinkle in the plan: miR-34a-5p impacts chemokine signaling by modulating CXCL10/CXCL11/CXCR3-axis in CD4
Hart M; Nickl L; Walch-Rueckheim B; Krammes L; Rheinheimer S; Diener C; Taenzer T; Kehl T; Sester M; Lenhof HP; Keller A; Meese E
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33229509
[TBL] [Abstract][Full Text] [Related]
5. Cxcl10 Chemokine Induces Migration of ING4-Deficient Breast Cancer Cells via a Novel Cross Talk Mechanism between the Cxcr3 and Egfr Receptors.
Tsutsumi E; Stricklin J; Peterson EA; Schroeder JA; Kim S
Mol Cell Biol; 2022 Feb; 42(2):e0038221. PubMed ID: 34871062
[TBL] [Abstract][Full Text] [Related]
6.
Berretta F; Piccirillo CA; Stevenson MM
Front Immunol; 2019; 10():425. PubMed ID: 30915078
[TBL] [Abstract][Full Text] [Related]
7. Th17 cells inhibit CD8
Wang D; Yu W; Lian J; Wu Q; Liu S; Yang L; Li F; Huang L; Chen X; Zhang Z; Li A; Liu J; Sun Z; Wang J; Yuan W; Zhang Y
J Hematol Oncol; 2020 Jun; 13(1):68. PubMed ID: 32503584
[TBL] [Abstract][Full Text] [Related]
8. Abundant expression of CXCL9 (MIG) by stromal cells that include dendritic cells and accumulation of CXCR3+ T cells in lymphocyte-rich gastric carcinoma.
Ohtani H; Jin Z; Takegawa S; Nakayama T; Yoshie O
J Pathol; 2009 Jan; 217(1):21-31. PubMed ID: 18980207
[TBL] [Abstract][Full Text] [Related]
9. Subsets of human CD4(+) regulatory T cells express the peripheral homing receptor CXCR3.
Hoerning A; Koss K; Datta D; Boneschansker L; Jones CN; Wong IY; Irimia D; Calzadilla K; Benitez F; Hoyer PF; Harmon WE; Briscoe DM
Eur J Immunol; 2011 Aug; 41(8):2291-302. PubMed ID: 21538345
[TBL] [Abstract][Full Text] [Related]
10. CXCR3+ T regulatory cells selectively accumulate in human ovarian carcinomas to limit type I immunity.
Redjimi N; Raffin C; Raimbaud I; Pignon P; Matsuzaki J; Odunsi K; Valmori D; Ayyoub M
Cancer Res; 2012 Sep; 72(17):4351-60. PubMed ID: 22798340
[TBL] [Abstract][Full Text] [Related]
11. T lymphocyte recruitment into renal cell carcinoma tissue: a role for chemokine receptors CXCR3, CXCR6, CCR5, and CCR6.
Oldham KA; Parsonage G; Bhatt RI; Wallace DM; Deshmukh N; Chaudhri S; Adams DH; Lee SP
Eur Urol; 2012 Feb; 61(2):385-94. PubMed ID: 22079021
[TBL] [Abstract][Full Text] [Related]
12. CXCL10 produced from hair follicles induces Th1 and Tc1 cell infiltration in the acute phase of alopecia areata followed by sustained Tc1 accumulation in the chronic phase.
Ito T; Hashizume H; Shimauchi T; Funakoshi A; Ito N; Fukamizu H; Takigawa M; Tokura Y
J Dermatol Sci; 2013 Feb; 69(2):140-7. PubMed ID: 23312578
[TBL] [Abstract][Full Text] [Related]
13. CXCL10/CXCR3 axis promotes the invasion of gastric cancer via PI3K/AKT pathway-dependent MMPs production.
Zhou H; Wu J; Wang T; Zhang X; Liu D
Biomed Pharmacother; 2016 Aug; 82():479-88. PubMed ID: 27470388
[TBL] [Abstract][Full Text] [Related]
14. LINC00152 mediates CD8
Ou J; Lei P; Yang Z; Yang M; Luo L; Mo H; Luo G; He J
J Mol Histol; 2021 Jun; 52(3):611-620. PubMed ID: 33709190
[TBL] [Abstract][Full Text] [Related]
15. Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression.
Berghuis D; Santos SJ; Baelde HJ; Taminiau AH; Egeler RM; Schilham MW; Hogendoorn PC; Lankester AC
J Pathol; 2011 Feb; 223(3):347-57. PubMed ID: 21171080
[TBL] [Abstract][Full Text] [Related]
16. STAT3 in CD8+ T Cells Inhibits Their Tumor Accumulation by Downregulating CXCR3/CXCL10 Axis.
Yue C; Shen S; Deng J; Priceman SJ; Li W; Huang A; Yu H
Cancer Immunol Res; 2015 Aug; 3(8):864-870. PubMed ID: 26025380
[TBL] [Abstract][Full Text] [Related]
17. Interferon regulatory factor 1(IRF-1) activates anti-tumor immunity via CXCL10/CXCR3 axis in hepatocellular carcinoma (HCC).
Yan Y; Zheng L; Du Q; Yazdani H; Dong K; Guo Y; Geller DA
Cancer Lett; 2021 May; 506():95-106. PubMed ID: 33689775
[TBL] [Abstract][Full Text] [Related]
18. TNFα-exposed bone marrow-derived mesenchymal stem cells promote locomotion of MDA-MB-231 breast cancer cells through transcriptional activation of CXCR3 ligand chemokines.
Shin SY; Nam JS; Lim Y; Lee YH
J Biol Chem; 2010 Oct; 285(40):30731-40. PubMed ID: 20650898
[TBL] [Abstract][Full Text] [Related]
19. Divergent roles of CXCR3 isoforms in promoting cancer stem-like cell survival and metastasis.
Li Y; Reader JC; Ma X; Kundu N; Kochel T; Fulton AM
Breast Cancer Res Treat; 2015 Jan; 149(2):403-15. PubMed ID: 25537642
[TBL] [Abstract][Full Text] [Related]
20. Treg-cell depletion promotes chemokine production and accumulation of CXCR3(+) conventional T cells in intestinal tumors.
Akeus P; Langenes V; Kristensen J; von Mentzer A; Sparwasser T; Raghavan S; Quiding-Järbrink M
Eur J Immunol; 2015 Jun; 45(6):1654-66. PubMed ID: 25754875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]